Yi Qingqing 4
4 · BeiGene, Ltd. · Filed Jun 24, 2022
Insider Transaction Report
Form 4
BeiGene, Ltd.BGNE
Yi Qingqing
Director
Transactions
- Award
Ordinary Shares
2022-06-22+16,692→ 24,492 total - Award
Share Option (Right to Buy)
2022-06-22−34,645→ 34,645 totalExercise: $11.98Exp: 2032-06-21→ Ordinary Shares (34,645 underlying)
Footnotes (3)
- [F1]Represents securities underlying RSUs. All RSUs will vest upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.
- [F2]The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. Each ADS represents 13 ordinary shares.
- [F3]The option shall become exercisable in full upon the earlier to occur of the first anniversary of the grant date or the date of the next annual general meeting; provided, however, that all vesting shall cease if the Reporting Person resigns from the board of directors or otherwise ceases to serve as a director, unless the board determines otherwise. Unvested securities are subject to accelerated vesting upon a change in control or certain termination events.